Massachusetts General Hospital: Renal Insufficiency trials

The registry lists 14 Renal Insufficiency studies with Massachusetts General Hospital as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 6Phase 2 2Phase 4 4No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Delayed Tolerance Through Mixed ChimerismRecruitingNCT05900401Phase 1/2
• Improving Care for Peritoneal Dialysis Patients With the CKD-PD AppCompletedNCT04797195Not applicableResults posted
• QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/PibrentasvirTerminatedNCT04515797Phase 4Results posted
• Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney TransplantCompletedNCT02945150Phase 4Results posted
• Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)CompletedNCT02314403Phase 1Results posted
• Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGHActive, not recruitingNCT04540380Phase 1
• HCV + to HCV - Kidney TransplantWithdrawnNCT04320290Phase 4
• Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney TransplantWithdrawnNCT03093740Phase 4
• Infusion of T-Regulatory Cells in Kidney Transplant Recipients (The ONE Study)CompletedNCT02091232Phase 1
• Comparison of Bovine Carotid Artery and Expanded Polytetrafluoroethylene (ePTFE) for Permanent Hemodialysis AccessCompletedNCT01021839Not applicable
• Calcium, Phosphate, Renal Impairment and Coronary Artery Disease in the Cardio-renal Syndrome, The CAPRICORN-CRS StudyWithdrawnNCT00853541
• The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular DiseasesCompletedNCT00842868
• Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living DonorWithdrawnNCT00476515Phase 1
• Rituximab Treatment to Block HLA Antibodies in Renal Transplant RecipientsWithdrawnNCT00261547Phase 1/2